This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.64% per year. These returns cover a period from January 1, 1988 through August 4, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $126.82, moving +0.71% from the previous trading session.
Why Should You Stay Away From Teladoc Health (TDOC) Now?
by Zacks Equity Research
Rising competition and decreasing business volumes place Teladoc Health (TDOC) in a precarious position.
Teladoc (TDOC) to Offer Remote Solutions for Canada Patients
by Zacks Equity Research
Teladoc Health (TDOC) has been selected by Infoway for providing remote patient monitoring solutions throughout Canada, thereby resulting in better health conditions.
Teladoc (TDOC) Gains But Lags Market: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $138.67, moving +0.05% from the previous trading session.
Cathie Wood Projects Market Rotation to Growth: ETFs to Play
by Sweta Jaiswal, FRM
Let's take a look at some ETFs poised to win from Wood's prediction of market rotation to growth investing.
American Well (AMWL) Down 59% YTD: Should You Still Hold?
by Zacks Equity Research
American Well (AMWL) is well placed in the booming telehealth industry on the back of its organic and inorganic growth profiles.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $139.29 in the latest trading session, marking a -1.96% move from the prior day.
Teladoc (TDOC) Gains As Market Dips: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $142.42 in the latest trading session, marking a +1.83% move from the prior day.
Amwell (AMWL) Buys Digital Care Startups to Enhance Market Share
by Zacks Equity Research
Amwell (AMWL) acquires digital health startups for fast expansion in the telehealth market.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed at $145.44 in the latest trading session, marking a -0.16% move from the prior day.
Teladoc (TDOC) Down 4.7% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Teladoc (TDOC) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
American Well (AMWL) Q2 Earnings Beat, 2H21 Visit View Cut
by Zacks Equity Research
American Well (AMWL) posts lower-than-expected loss for Q2. The spread of Delta variant compels the company to slash 2021 guidance.
Teladoc Health (TDOC) Q2 Loss Wider Than Expected, Worsen Y/Y
by Zacks Equity Research
Teladoc Health's (TDOC) Q2 earnings endure high expenses. Guidance shows tapering of growth.
Teladoc (TDOC) Reports Q2 Loss, Tops Revenue Estimates
by Zacks Equity Research
Teladoc (TDOC) delivered earnings and revenue surprises of -45.76% and 0.43%, respectively, for the quarter ended June 2021. Do the numbers hold clues to what lies ahead for the stock?
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $152.87, moving -0.29% from the previous trading session.
Will Teladoc (TDOC) Q2 Earnings Show Weak Telehealth Demand?
by Zacks Equity Research
Teladoc's (TDOC) Q2 results are likely to reflect a rise in revenues but overall tepid demand as patients started visiting doctors' clinics for in-person checkups.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $153.32, marking a -0.98% move from the previous day.
Analysts Estimate Teladoc (TDOC) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Teladoc (TDOC) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Dexcom's (DXCM) Digital Network Benefits From Latest FDA Nod
by Zacks Equity Research
Recent regulatory clearance of Dexcom's (DXCM) real-time APIs is expected to aid diabetics as well as their care providers in accessing GCM data.
Teladoc (TDOC), Microsoft Team Up to Offer Better Virtual Care
by Zacks Equity Research
Teladoc Health (TDOC) collaborates with Microsoft in a bid to ease administrative workflows for clinicians and offer enhanced virtual care to patients.
Teladoc (TDOC) Dips More Than Broader Markets: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $146.21, marking a -1.77% move from the previous day.
Here's Why You Should Hold Teladoc Health (TDOC) in Your Portfolio
by Zacks Equity Research
Despite a great run on the bourses last year, Teladoc Health (TDOC) suffers tepid demand while stiff competition calls for keeping a close watch on the stock.
Teladoc (TDOC) Stock Moves -0.2%: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $157.94, marking a -0.2% move from the previous day.
Teladoc (TDOC) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
In the latest trading session, Teladoc (TDOC) closed at $164.64, marking a -0.99% move from the previous day.
Teladoc (TDOC) Outpaces Stock Market Gains: What You Should Know
by Zacks Equity Research
Teladoc (TDOC) closed the most recent trading day at $163.27, moving +1.73% from the previous trading session.